Correlation Analysis
Eli Lilly & Co. vs Marsh
LLY vs MRSH
+0.610
Moderate positive
When one moves up, the other tends to follow.
Eli Lilly & Co.
↗LLY
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Market cap 828.2B · 50,000 employees
Marsh
↗MRSH
Marsh McLennan is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (a management and economic consultancy). About half of its revenue is generated outside the US.
Market cap 84.5B · 55,700 employees
Time Series
Relative Performance
Who Moves First
MRSH leads LLY by 1 day
MRSH tends to move before LLY.
After testing 13 timing shifts, the strongest relationship was +0.613 (they moved in the same direction).
Do They Crash Together?
Correlation by Market Regime
How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.
Both Rising
-0.150
6 periods · Return correlation when both series rose
Both Falling
+0.282
12 periods · Return correlation when both series fell
Diverging
-0.515
17 periods · Return correlation when series moved apart
R-Squared
37.2%
Share of variance in one series explained by the other.
Trend Agreement
55.4%
How often both series moved in the same direction period-to-period.
Overlap Quality
57
Thin shared window — 57 usable pairs.
Significance
p < 0.001
95% CI: [0.415, 0.751]
Scatter
XY Regression
Pipeline
Data quality details
Pipeline
Data quality details
Pipeline Summary
57 paired data points survived the daily window.
Raw input
1,254
57
Normalized
1,254
57
Prepared
1,254
57
Aligned
57
57
Invalid removed
0
A: 0 / B: 0
Duplicates removed
0
A: 0 / B: 0
Alignment drops
1,197
A: 1197 / B: 0
Series A
Eli Lilly & Co.
LLY
Market cap 828.2B · 50,000 employees
Stock · 1,254 raw → 1,254 prepared
Series B
Marsh
MRSH
Market cap 84.5B · 55,700 employees
Stock · 57 raw → 57 prepared
Sign agreement
100.0%
How often both values share the same sign.
Zero crossings
5
Estimated crossover points between normalized spreads.
Slope
0.0612
Linear regression slope.
Intercept
117.4561
Linear regression intercept.
Related Extremes
Highest and Lowest Correlated
Saved 6 hours ago · ID: stock-lly-vs-stock-mrsh-daily